These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21424282)

  • 1. Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy.
    McCulloch T; Prayle A; Lunn A; Watson AR
    Pediatr Nephrol; 2011 Jul; 26(7):1163-6. PubMed ID: 21424282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients.
    Hill PA; Prince HM; Power DA
    Pathology; 2000 Aug; 32(3):166-70. PubMed ID: 10968388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide induced renal rickets.
    Lionel AP; Chinnaswamy G; John RR; Mathai S
    Indian J Pediatr; 2014 Sep; 81(9):943-5. PubMed ID: 23912821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid.
    Matsuura T; Wakino S; Yoshifuji A; Nakamura T; Tokuyama H; Hashiguchi A; Konishi K; Iwasa T; Shoji M; Hosono A; Ohashi K; Chuman H; Itoh H
    CEN Case Rep; 2014 Nov; 3(2):226-231. PubMed ID: 28509207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Ifosfamide toxicity: kidney pathology and pathophysiology.
    Akilesh S; Juaire N; Duffield JS; Smith KD
    Am J Kidney Dis; 2014 May; 63(5):843-50. PubMed ID: 24518127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An uncommon presentation of an uncommon nephropathy: the karyomegalic interstitial nephritis.
    Lucisano G; Comi N; Cianfrone P; Andreucci M; Piraina V; Talarico R; Giannakakis K; Fuiano G
    J Nephrol; 2013; 26(6):1188-91. PubMed ID: 23553526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide nephrotoxicity in paediatric cancer patients.
    Ashraf MS; Brady J; Breatnach F; Deasy PF; O'Meara A
    Eur J Pediatr; 1994 Feb; 153(2):90-4. PubMed ID: 8157032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy.
    Knoppert SN; Keijzer-Veen MG; Valentijn FA; van den Heuvel-Eibrink MM; Lilien MR; van den Berg G; Haveman LM; Stokman MF; Janssens GO; van Kempen S; Broekhuizen R; Goldschmeding R; Nguyen TQ
    J Pathol; 2023 Dec; 261(4):455-464. PubMed ID: 37792603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas.
    Marina NM; Poquette CA; Cain AM; Jones D; Pratt CB; Meyer WH
    J Pediatr Hematol Oncol; 2000; 22(2):112-8. PubMed ID: 10779023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
    Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
    J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi syndrome with karyomegalic interstitial nephritis after ifosfamide treatment for osteosarcoma: a case report.
    Kita Y; Shirai S; Koyama T; Makinouchi R; Machida S; Matsui K; Koike J; Imai N
    CEN Case Rep; 2024 Jul; ():. PubMed ID: 38955949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy.
    Friedlaender MM; Haviv YS; Rosenmann E; Peylan-Ramu N
    Am J Nephrol; 1998; 18(2):131-3. PubMed ID: 9569955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
    Meyer WH; Kun L; Marina N; Roberson P; Parham D; Rao B; Fletcher B; Pratt CB
    J Clin Oncol; 1992 Nov; 10(11):1737-42. PubMed ID: 1403056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
    Stöhr W; Paulides M; Bielack S; Jürgens H; Treuner J; Rossi R; Langer T; Beck JD
    Pediatr Blood Cancer; 2007 Apr; 48(4):447-52. PubMed ID: 16628552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyomegalic interstitial nephropathy following ifosfamide therapy.
    Jayasurya R; Srinivas BH; Ponraj M; Haridasan S; Parameswaran S; Priyamvada PS
    Indian J Nephrol; 2016; 26(4):294-7. PubMed ID: 27512305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marriage and fertility in long-term survivors of childhood, adolescent and young adult (AYA) high-grade sarcoma.
    Yonemoto T; Takahashi M; Maru M; Tomioka A; Saito M; Araki Y; Tazaki M; Tsuchiya M; Iwata S; Kamoda H; Ishii T
    Int J Clin Oncol; 2016 Aug; 21(4):801-807. PubMed ID: 26792434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.
    Oberlin O; Habrand JL; Zucker JM; Brunat-Mentigny M; Terrier-Lacombe MJ; Dubousset J; Gentet JC; Schmitt C; Ponvert D; Carrié C
    J Clin Oncol; 1992 Sep; 10(9):1407-12. PubMed ID: 1517783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Karyomegalic interstitial nephritis: an atypical case].
    Dugo M; Laurino L; Di Martino A; Brunello A; Caberlotto A; Gatti P; Mangino M; Mastrosimone S; Pasi A; Palminteri G; Puggia R; Rizzolo M; Toffolo K; Virgilio B; Zagatti R; Maresca MC
    G Ital Nefrol; 2016; 33(4):. PubMed ID: 27545629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyomegalic interstitial nephritis: report of 3 new cases and review of the literature.
    Monga G; Banfi G; Salvadore M; Amatruda O; Bozzola C; Mazzucco G
    Clin Nephrol; 2006 May; 65(5):349-55. PubMed ID: 16724656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
    Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
    J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.